better choice for many
RE: better choice for many
We must remember this is a single dose vaccine versus two doses for Pfizer, BioNTech vaccine and the Moderna vaccine.
I think the Pfizer vaccine after the first dose is achieved maybe a 52% efficacy or something like that. Johnson & Johnson’s results are significantly better than what we’ve seen from the single-dose of Pfizer.
I think that’s the thing to keep in mind that a single dose vaccine, there’s definitely some advantages and this isn’t necessarily bad efficacy at all for one dose.
The FDA has always said 50% is enough to get emergency use authorization. Certainly anything above 50%, anything above in the 66% range, especially in the U.S. it’s 72 if we don’t start having variants, I think it’s pretty good and certainly going to help reduce the spread. As you’re reducing the spread then that ultimately will help us get rid of the virus.